Literature DB >> 5921463

Erythema multiforme, drugs, and ulcerative colitis.

A J Cameron, J H Baron, B L Priestley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5921463      PMCID: PMC1944727          DOI: 10.1136/bmj.2.5523.1174

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  25 in total

1.  LONG-ACTING SULPHONAMIDES ASSOCIATED WITH STEVENS-JOHNSON SYNDROME.

Authors:  J BEVERIDGE; M HARRIS; G WISE; L STEVENS
Journal:  Lancet       Date:  1964-09-12       Impact factor: 79.321

2.  THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS.

Authors:  F C EDWARDS; S C TRUELOVE
Journal:  Gut       Date:  1964-02       Impact factor: 23.059

3.  Erythema multiforme associated with sulfamethoxypyridazine admistration.

Authors:  R C GARNER
Journal:  N Engl J Med       Date:  1959-12-03       Impact factor: 91.245

4.  Skin lesions associated with chronic ulcerative colitis.

Authors:  M L KELLEY
Journal:  Am J Dig Dis       Date:  1962-03

5.  Unique allergic response to sulfisoxazole gantrisin; report of a case.

Authors:  J B DAVIS; M TACHDJIAN
Journal:  J Am Med Assoc       Date:  1956-05-19

6.  Erythema multiforme bullosum following phenylbutazone treatment for arthritis; report of a fatal case.

Authors:  R B CONE; C A HANNIGAN; R TEICHER
Journal:  AMA Arch Derm Syphilol       Date:  1954-06

7.  Stevens-Johnson syndrome and granulocytopenia after phenylbutazone.

Authors:  S J STEEL; J L MOFFATT
Journal:  Br Med J       Date:  1954-04-03

8.  Unusual reaction following use of phenylbutazone (butazolidin).

Authors:  R CHARET; I SIEGEL
Journal:  J Am Med Assoc       Date:  1953-02-14

9.  Severe toxic reactions associated with sulfamethoxypyridazine (kynex).

Authors:  J SALVAGGIO; F GONZALEZ
Journal:  Ann Intern Med       Date:  1959-07       Impact factor: 25.391

10.  Fatal case of toxic erythema after chlorpropamide (Diabinese).

Authors:  G L Tullett
Journal:  Br Med J       Date:  1966-01-15
View more
  3 in total

1.  Skin lesions in ulcerative colitis.

Authors:  M L Johnson; H T Wilson
Journal:  Gut       Date:  1969-04       Impact factor: 23.059

Review 2.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

Review 3.  Clinical pharmacokinetics of sulphasalazine.

Authors:  K M Das; R Dubin
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.